MAGNIM KISSAO: Open Payments
NPI 1982261145 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 8 payments from 6 companies in 2025. Trend: 2023 $36 · 2024 $213 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $335 |
| Alnylam Pharmaceuticals Inc. | 2 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $33 |
| BridgeBio Pharma, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Rapiblyk, AMVUTTRA, ELIQUIS, LifeVest, Attruby, FARXIGA.
Industry payments across NY — which companies pay providers there.
